ATCvet code alterations
| Previous ATCvet code | ATCvet level name | New ATCvet code | |
|---|---|---|---|
| QL01EX17 | capmatinib | QL01EP01 | |
| QL01EX21 | tepotinib | QL01EP02 | |
| QL04AA58 | efgartigimod alfa | QL04AL01 | |
| QL04AG16 | rozanolixizumab | QL04AL02 |
Last updated: 2026-01-20
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer